Pan-HDAC inhibitors panobinostat and vorinostat/suberoylanilide hydroxamic acid (SAHA) cause hyperacetylation of nuclear HSP90, degrading DNA repair machinery proteins BRCA1, ATR, and CHK1 in breast cancer cells [9]. The gene discussed is HDAC9; the disease is breast carcinoma.